Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 10813033)

Published in AIDS Patient Care STDS on September 01, 1999

Authors

V E Proctor1, A Tesfa, D C Tompkins

Author Affiliations

1: Department of Preventive Medicine, State University of New York at Stony Brook, USA. NIBC1112@aol.com

Articles citing this

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57

A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49

Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care (2009) 2.18

A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr (2006) 1.85

Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl) (2013) 1.68

Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med (2006) 1.41

How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2006) 1.39

Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev (2003) 1.35

Adherence discourse among African-American women taking HAART. AIDS Care (2002) 1.22

Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs. AIDS Patient Care STDS (2011) 1.05

Patient communication tools to enhance ART adherence counseling in low and high resource settings. Patient Educ Couns (2012) 0.93

Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. AIDS Care (2015) 0.84

Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav (2015) 0.82

Scutellaria baicalensis decreases ritonavir-induced nausea. AIDS Res Ther (2005) 0.79

Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model. AIDS Res Ther (2009) 0.77